Ordeniza, Juncris P.
HRN: 20-79-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2024
MUPIROCIN 2%, 15G (TUBE)
01/01/2024
01/08/2024
TOPICAL
Topical
BID
Infected Colostomy Site
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes